• An Early-Stage THx, Dx & Device Focus:

    Welcome to the site formerly known as [Colorado] Life Science Deal Flow. This new version looks at the biopharma world primarily from an early-stage financing perspective. Be certain to visit our companion site, a FREE Venture Capital dBase, OnBioVC.com, and subscribe by email or RSS.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

Thanks to Fred Wilson Managing Partner at Union Square Ventures for the transparent post on his investment track record in early-stage venture deals. Though Fred’s foci is in software and web-based technologies I feel comfortable stating, from what I have seen, heard, read, etc. that life science managing directors and partners approach current and potential [...]

The Colorado BioScience Association has released their winners for the 2007 Awards Program to correlate with next weeks official awards presentation at the BioWest luncheon (7 December) more info and register to attend (here).
And the envelope please…

The Lifetime Achievement Award goes to (insert drum-roll sound effect here) Dr. Larry Gold founder, chair and Chief [...]

It is exciting to see how the Colorado community is heating up around biomarkers and diagnostics. What is even hotter to me is when one of these molecular diagnostics forge an intimate relationship with and become a companion to enabling a genetically targeted therapeutic.
Well, we here in Colorado are lucky to have one such company [...]

Dear Friends of Colorado Bio,
You are cordially invited to attend the BioBeers gala the evening of 6 December 7:30pm (@ Harry’s Bar 818 17th St Denver). We hope you are able to join us following what is certain to be an enthralling first day of the BioWest Conference and Expo.
For more information about BioBeers and [...]

InViragen (Ft. Collins) is committed to developing life-saving vaccines to protect against emerging infectious diseases worldwide and continues on a very positive trajectory. Building upon last years $2.7M NIH Dengue vax grant InViragen has now confirmed financial support from the Pediatric Dengue Vaccine Initiative. This non-dilutive financing will enable the manufacture of the Dengue vax, [...]

If you are looking for a vivarum and Contract Research Organization to conduct pre-clinical GLP animal studies than looking no further than Ft. Collins’ High Quality Research. In addition to directing studies HQR also provides protocol development, implementation and quality assurance. There is also the option to run studies with HRQ staff or your own [...]

Planning on a post-Turkey tryptophan hangover tomorrow? Does the tryptophan myth even ring true? Well, while turkey does contain high levels of tryptophan, the amount is comparable to that contained in most other meats (chicken, beef and even fish). The Thanksgiving sedation may have more to do with what is consumed along with the turkey, [...]

If Chemizon had not been on your radar well consider yourself now in the loop…if you have been looking for a local drug discovery platform then look no further than Longmont’s Chemizon. Back in 2006 Tony Piscopio, Ph.D. who co-founded Array Biopharma (NASDAQ: ARRY) departed to found Chemizon.
Chemizon is a provider of drug discovery and [...]

OK…it was just a few weeks ago when I highlighted Celgene’s (NASDAQ: CELG) concentrated activity in Colorado bio, take a look (here). The Colorado bioscape has proved to be an incredibly active market for big pharma in the last year, accounting for nearly a whopping $7 billion in transactions! Just to quickly review these deals [...]

Array Biopharma (NASDAQ: ARRY) is really hitting on all cylinders with eight-wholly owned development programs and a rich portfolio of discovery programs. Let’s take a closer look under the hood…shall we?ARRY 162 – neared completion of a Phase I trial with of adding to methotrexate in patients with stable rheumatoid arthritis. Plans are to begin [...]

Congratulations to Kevin Johansen and the very talented team who executed the Angel Capital Summit yesterday. What an incredible turnout of sophisticated angel investors. I believe in excess of 40 companies presented, naturally I stuck to the bio-track and was not disappointed.
Several Fitzsimons BioBusiness Partners related entities presented to packed rooms and were unable to [...]

Illumasonix (Boulder) is developing a new non-invasive vascular disease detection procedure. This process will easily and non-invasively provide real-time assessment of detailed blood flow patterns within the cardiovascular system.
Current blood-flow diagnostics for cardiovascular and neurovascular diseases utilize ultrasound and MRI technology, which are limited in their capacity to localize areas of disease progression. Ultrasound Doppler [...]

GlobeImmune (Louisville) announced encouraging results from the higher dose cohorts of the randomized, placebo-controlled Phase Ib trial evaluating safety, immunogenicity and efficacy of GI-5005 in patients with chronic hepatitis C infection. The data yielded a favorable safety profile with the dose escalation to the highest planned dose without dose limiting toxicity; strong trends for [...]

« Previous Entries  Next Page »

to top of page...


 
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com